Full Answer
What is the area of medicine dealing with diseases of the blood?
Is Sobi's annual report available?
About this website
Is patient assistance program legitimate?
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical manufacturers and are promoted as a safety net for Americans who have no health insurance or are underinsured.
Is Synagis covered by insurance?
Synagis is covered under the member's medical benefit. For the 2019-2020 RSV season, it is mandatory for all participating providers to obtain Synagis for Independence members through PerformSpecialty®, an independent company.
How much is Synagis out of pocket?
The cost for Synagis intramuscular solution (100 mg/mL) is around $1,844 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Does Organon have a patient assistance program?
The Organon Co-pay Assistance Program offers assistance to eligible, privately insured patients who need help affording their medication. For product-specific information, please visit your medication website.
How do you qualify for Synagis?
SYNAGIS gives babies who are born prematurely (at or before 35 weeks, and who are 6 months of age or less at the beginning of RSV season) the infection-fighting antibodies they lack, helping protect their vulnerable lungs from RSV.
Does Medicare cover Synagis?
Do Medicare prescription drug plans cover Synagis? No. In general, Medicare prescription drug plans (Part D) do not cover this drug.
Why is Synagis so expensive?
Alex Zukiwski, chief medical officer of MedImmune, which was acquired last year by AstraZeneca PLC, says the Synagis price reflects the complexity of developing and manufacturing biological products, as well as the company's commitment to RSV prevention and development of a vaccine.
Is there a generic for Synagis?
GENERIC NAME: PALIVIZUMAB - INJECTION (pal-ih-VYE-zyou-mab)
How quickly does Synagis work?
According to the guidelines set by the AAP, an infant at high risk in the hospital should get a dose of Synagis 48 to 72 hours before going home, or soon after leaving the hospital during RSV season. The antibodies from Synagis help your child for about a month.
How can I get a free inhaler?
Prescription assistance programs (PAPs) are designed to provide inhalers and other asthma drugs free of charge or at a highly discounted price to lower-income individuals and families. Copay assistance programs (CAPs) cover a portion of drug copay costs for people with health insurance.
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
What products does Organon make?
US Organon ProductsASMANEX® HFA. (mometasone furoate) 50 mcg, 100 mcg, 200 mcg Inhalation Aerosol. ... ASMANEX® TWISTHALER® (mometasone furoate inhalation powder) 110 mcg, 220 mcg. ... DULERA® ... FOLLISTIM® AQ Cartridge. ... Ganirelix Acetate Injection. ... NEXPLANON® ... An Organon Biosimilars Product. ... PREGNYL®More items...
Why is Synagis so expensive?
Alex Zukiwski, chief medical officer of MedImmune, which was acquired last year by AstraZeneca PLC, says the Synagis price reflects the complexity of developing and manufacturing biological products, as well as the company's commitment to RSV prevention and development of a vaccine.
How much is the RSV shot?
The drug is called Synagis (palivizumab) and it costs between $5,000 and $9,000 per infant per year — still as expensive as when it first became available almost 20 years ago.
When should Synagis be given?
Your child's healthcare provider will give you detailed instructions on when SYNAGIS will be given. SYNAGIS is needed every 28-30 days during the RSV season. Each injection of SYNAGIS helps protect your child from severe RSV disease for about 1 month.
Who qualifies for RSV vaccine?
Very young infants, especially those 6 months and younger. Children younger than 2 years old with chronic lung disease or congenital heart disease. Children with suppressed immune systems. Children who have neuromuscular disorders, including those who have difficulty swallowing or clearing mucus secretions.
Who We Are | Sobi North America
We Care About Rare Disease Patients. Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.
we care about rare disease patients | Sobi North America
Sobi is dedicated to developing and delivering innovative therapies to improve the lives of rare disease patients.
Swedish Orphan Biovitrum - Wikipedia
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (May 2020) (Learn how and when to remove this template message)
Products | Sobi
Alphabetical listings of key products and of other products. Doptelet ® (avatrombopag) is an orally administered thrombopoietin receptor agonist (TPO-RA) that mimics the biologic effects of TPO in stimulating the development and maturation of megakaryocytes, resulting in increased platelet count. It is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease ...
What is the area of medicine dealing with diseases of the blood?
Haematology is the area of medicine dealing with diseases of the blood.
Is Sobi's annual report available?
Sobi’s Annual and Sustainability Report 2020 is now available.
Patient Consent Form
A document for parents/caregivers to complete to allow SYNAGIS CONNECT ® enrollment
Universal Enrollment and Prescription Form
Provides the required information to prescribe SYNAGIS through a specialty pharmacy and/or enroll a patient in SYNAGIS CONNECT ®
Is a thrombocytopenia treatment approved?
It is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure, and for the treatment of primary chronic immune thrombocytopenia in adult patients who are refractory to other treatments such as corticosteroids or immunoglobulins.
Is Orfadin a good treatment for alkaptonuria?
Orfadin is also indicated for the treatment of adult patients with alkaptonuria (AKU). Nitisinone is a competitive inhibitor of an enzyme in the tyrosine metabolism. By inhibiting the normal catabolism of tyrosine in patients with HT-1 and AKU, nitisinone prevents the accumulation of harmful metabolites in the body.
IMPORTANT PRODUCT INFORMATION
SYNAGIS, 50 mg and 100 mg for injection, is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children:
IMPORTANT PRODUCT INFORMATION
SYNAGIS, 50 mg and 100 mg for injection, is a prescription medication that is used to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children:
IMPORTANT SAFETY INFORMATION
Children should not receive SYNAGIS if they have ever had a severe allergic reaction to it.
What is the area of medicine dealing with diseases of the blood?
Haematology is the area of medicine dealing with diseases of the blood.
Is Sobi's annual report available?
Sobi’s Annual and Sustainability Report 2020 is now available.
